文献速递糖尿病骨质疏松与钙磷/甲状旁腺

外源性GIP和GLP-2对2型糖尿病患者骨转换的影响

Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

该研究纳入10名2型糖尿病男性,采用随机交叉设计,分别皮下注射GIP、GLP-2或安慰剂,观察骨转换指标变化。结果显示GIP和GLP-2均显著降低CTX至基线的66±7.8%和74±5.9%,且对CTX和P1NP的影响程度与既往在健康个体中观察到的相同。

要点

  • 在2型糖尿病男性中,皮下注射GIP和GLP-2均急性降低骨吸收标志物CTX。
  • GIP使P1NP和硬骨素急性升高,而GLP-2使P1NP降低。
  • GIP和GLP-2对CTX和P1NP的影响程度与既往健康个体研究结果相同。

核心结论

  • 皮下注射GIP和GLP-2对2型糖尿病患者的CTX和P1NP影响程度与既往在健康个体中观察到的相同。

研究设计与样本

  • 研究纳入10名2型糖尿病男性,采用随机交叉设计,参与者分别在3个测试日清晨空腹接受皮下注射GIP、GLP-2或安慰剂。

主要发现

  • GIP和GLP-2分别将CTX显著降低至基线的66±7.8%和74±5.9%,与安慰剂后相比P=0.001。
  • GIP后P1NP和硬骨素急性升高,而GLP-2后P1NP降低。
  • GLP-2后PTH水平降至基线的67±2.5%,GIP后仅降至86±3.4%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Individuals with type 2 diabetes (T2D) have an increased risk of bone fractures despite normal or increased bone mineral density. The underlying causes are not well understood but may include disturbances in the gut-bone axis, in which both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-2 (GLP-2) are regulators of bone turnover. Thus, in healthy fasting participants, both exogenous GIP and GLP-2 acutely reduce bone resorption. OBJECTIVE: The objective of this study was to investigate the acute effects of subcutaneously administered GIP and GLP-2 on bone turnover in individuals with T2D. METHODS: We included 10 men with T2D. Participants met fasting in the morning on 3 separate test days and were injected subcutaneously with GIP, GLP-2, or placebo in a randomized crossover design. Blood samples were drawn at baseline and regularly after injections. Bone turnover was estimated by circulating levels of collagen type 1 C-terminal telopeptide (CTX), procollagen type 1 N-terminal propeptide (P1NP), sclerostin, and PTH. RESULTS: GIP and GLP-2 significantly reduced CTX to (mean ± SEM) 66 ± 7.8% and 74 ± 5.9% of baseline, respectively, compared with after placebo (P = .001). In addition, P1NP and sclerostin increased acutely after GIP whereas a decrease in P1NP was seen after GLP-2. PTH levels decreased to 67 ± 2.5% of baseline after GLP-2 and to only 86 ± 3.4% after GIP. CONCLUSION: Subcutaneous GIP and GLP-2 affect CTX and P1NP in individuals with T2D to the same extent as previously demonstrated in healthy individuals.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Skov-Jeppesen K, Christiansen CB, Hansen LS, et al. Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes. J Clin Endocrinol Metab. 2024. PMID: 38217866. doi:10.1210/clinem/dgae022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。